ARCHIVES

FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting

This article is from The Cancer Letter archive.

Vol. 02 No. 12 | March 19, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

New Grant Concepts Totaling $3 million a Year Approved, With New Contract, Two Recompetitions

July 10, 1987

Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion.

December 2, 2005